EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan targeting proteins in the brains of sufferers of the debilitating disease, will cost 3.08 ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

Those with one copy are at increased risk too. Leqembi, which is developed by the Japanese pharmaceutical company Eisai and ...

Biogen’s first entry into the amyloid-targeting drugs category with Eisai-partnered Aduhelm (aducanumab) was a disaster, with controversy blighting its approval and launch, rendering it ...

Delhi Air Pollution: Delhi continued to battle a worsening pollution crisis, with its air quality plunging into the 'severe' category for a fourth consecutive day.

When Labour took power in July it inherited an economy that had taken a beating but was starting to recover at speed. Not anymore.

Social media star Jake Paul defeated boxing legend Mike Tyson in a highly anticipated fight. There is an age difference of over three decades between the two contenders. The Friday night win for the ...